Atea Pharmaceuticals Inc. (AVIR)
3.20
0.05 (1.59%)
At close: Jan 15, 2025, 12:33 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -135.96M | -115.91M | 121.19M | -10.95M | -14.03M | -9.06M |
| Depreciation & Amortization | 416.00K | 260.00K | 29.00K | 19.00K | 17.00K | 17.00K |
| Stock-Based Compensation | 49.43M | 46.72M | 39.62M | 7.46M | 624.00K | 414.00K |
| Other Working Capital | 14.46M | -44.60M | -258.13M | 301.37M | 422.00K | 815.00K |
| Other Non-Cash Items | 33.11M | -5.46M | 29.39M | 13.80M | 501.00K | 538.00K |
| Deferred Income Tax | -48.56M | n/a | -29.39M | -13.80M | -501.00K | n/a |
| Change in Working Capital | 16.16M | -46.59M | -247.84M | 300.20M | 579.00K | 725.00K |
| Operating Cash Flow | -85.39M | -120.98M | -87.00M | 296.73M | -12.81M | -7.91M |
| Capital Expenditures | n/a | -1.94M | -4.00K | -26.00K | -2.00K | -12.00K |
| Acquisitions | n/a | 453.47K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -562.36M | -545.35M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 602.66M | 91.89M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -453.47K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 40.30M | -455.41M | -4.00K | -26.00K | -2.00K | -12.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 257.00K | 140.00K | n/a | 214.12M | n/a | 54.84M |
| Financial Cash Flow | 257.00K | 370.00K | 1.47M | 531.75M | -15.00K | 27.48M |
| Net Cash Flow | -44.84M | -576.02M | -85.54M | 828.46M | -12.83M | 19.56M |
| Free Cash Flow | -85.39M | -122.92M | -87.01M | 296.71M | -12.82M | -7.92M |